Volume 6; Issue supp-S4

Main
European Neuropsychopharmacology
Volume 6; Issue supp-S4

European Neuropsychopharmacology

Volume 6; Issue supp-S4

1

Author index

Journal:

European Neuropsychopharmacology

Year:

1996

File:

PDF, 650 KB

1996

2

S.08.01 - Genetics and function of GABAA-receptor subtypes

H. Möhler, J.-M. Fritschy, D. Benke, J. Benson, B. Lüscher

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

3

S.08.02 - Neuroactive steroids acting at GABAA receptors

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 328 KB

english, 1996

4

S.08.03 - Pharmacology of benzodiazepine receptor ligands with different intrinsic efficacy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 326 KB

english, 1996

5

S.08.05 - PET imaging of benzodiazepine receptors and their relationship to anxiety disorders

D.J. Nutt, A.L. Malizia, S.J. Wilson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

6

S.09.01 - The dopamine receptors and schizophrenia therapy

Olivier Civelli, Deborah Hartman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 325 KB

english, 1996

7

S.09.02 - Serotonin-related strategies for the treatment of schizophrenia

H.Y. Meltzer, J. Ichikawa, T. Kuroki, B. Roth

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 332 KB

english, 1996

8

S.09.03 - Adenosine A2A agonists: A potential, new type of atypical antipsychotics

S.O. Ögren, S. Ferré, R. Rimondini, K. Fuxe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

9

S.06.05 - A review of the efficacy of “Seroquel” (quetiapine) in the treatment of the positive and negative symptoms of schizophrenia

J.S.E. Hellewell, B.C. Hurst

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

10

S.09.05 - Selective versus non-selective neuroleptics: Advantages and disadvantages

M. Ackenheil, J.-P. Macher

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

11

S.10.01 - Rapid onset of antidepressant action in an animal model of depression

M. Papp, P. Willner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

12

S.10.02 - Combination treatments with rapid onset of action in major depression

P. Blier, B. Bergeron

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

13

S.10.03 - BIMT 17: A putative fast acting antidepressant

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

14

S.10.05 - Does Venlafaxin have early onset?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

15

S.11.01 - The amyloid hypothesis in Alzheimer's disease and its implication for therapy: A review of evidence

K. Beyreuther, P.J. Tienari, E. Ikonenen, G. Multhaup, T. Hartmann, M. Simons, C.G. Dotti, C.L. Masters

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 319 KB

english, 1996

16

S.11.02 - Neuropathology of Alzheimer's disease with special reference to neurofibrillary tangles

H. Braak, E. Braak, D. Yilmazer, J. Bohl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 330 KB

english, 1996

17

S.11.05 - Role of inflammation, Apo E, and antichymotrypsin in Alzheimer's disease

Huntington Potter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 170 KB

english, 1996

18

S.12.01 - Molecular genetic studies in affective disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 329 KB

english, 1996

19

S.12.02 - Antisense “knockout” of brain dopamine receptors: Potential antipsychotics?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 173 KB

english, 1996

20

S.12.03 - Immediate early genes: Functions and responses to drugs

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 315 KB

english, 1996

21

S.12.04 - Possible cross-tolerance between haloperidol and clozapine towards Fos-protein induction in some rat brain regions

Jantiena B. Sebens, Tineke Koch, Jakob Korf

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 314 KB

english, 1996

22

S.12.05 - Neurotransmitter receptors, genes and schizophrenia

Gavin P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 324 KB

english, 1996

23

S.13.03 - Epileptic agents in bipolar depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

24

S.13.04 - Lithium withdrawal: Clinical consequences and changes in brain perfusion

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

25

S.16.01 - Stress and depression: A hypothesis on their biological interface

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 303 KB

english, 1996

26

S.16.03 - Disruption of circadian rhythms in possible animal models for depression

F.W. Turek, P. Zee, O. Buxton, O. Van Reeth, P. Penev

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 326 KB

english, 1996

27

S.16.05 - The behavioral and neural biology of “social stress”

K.A. Miczek, W. Tornatzky, A.M.M. van Erp

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 323 KB

english, 1996

28

S.17.01 - Social phobia: Treatment usage in general health care

E. Weiller, J.C. Bisserbe, J.P. Lépine, P. Boyer, Y. van Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

29

S.17.02 - Cognitive and behaviourial therapies for social phobia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 321 KB

english, 1996

30

S.17.03 - Treatment of social phobia with SSRIs

J.H. Greist, D.J. Katzelnick, J.W. Jefferson, K.A. Kobak

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

31

S.17.04 - RIMAs in social phobia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

32

S.17.05 - The need for treatment of social phobia

J.A. Costa e Silva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

33

S.18.01 - 5-HT1A receptors, anxiety and stress: Behavioural, neuroendocrine and physiological interfaces

B. Olivier, L. Groenink, T. Hijzen, J. van der Gugten

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 319 KB

english, 1996

34

S.18.03 - 5HT2 receptor subtypes: Central localisation, roles and possible therapeutic applications of agonists and antagonists

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 337 KB

english, 1996

35

S.18.04 - Neurotherapeutic potential of 5-HT3 receptor antagonists

M.G. Palfreyman, S.M. Sorenson, M.W. Gittos, P.C. Moser, J.H. Kehne, M.W. Dudley, J.R. Fozard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 332 KB

english, 1996

36

S.19.05 - A meta-analysis of magnetic resonance imaging studies in schizophrenia

A. Vita, M. Dieci, F. Tenconi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

37

S.21.02 - A double action antidepressant: Venlafaxine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 302 KB

english, 1996

38

S.21.04 - Mirtazapine: A dual action antidepressant which does not affect monoamine reuptake

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

39

S.21.05 - Milnacipran, a double noradrenaline and serotonin reuptake inhibiting antidepressant

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

40

S.22.04 - The future of CCK agonists and antagonists in panic disorder and anxiety

M. Bourin, E. Vasar

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

41

S.22.05 - Time course of inositol treatment of panic disorder

J. Benjamin, M. Fux, R.H. Belmaker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

42

S.23.03 - Pharmacological discrimination of native and recombinant rat and human N-methyl-D-aspartate receptors

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

43

S.23.04 - Molecular pharmacology of NMDA receptors

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

44

S.23.05 - The pharmacology of native NMDA receptor subtypes

C. Carter, D. Fage, M. Klarica, M. Nankai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 317 KB

english, 1996

45

S.24.01 - The development of brain and behavior

Thomas R. Insel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

46

S.24.03 - Neonatal pain and stress: Neural adaptations and long-term consequences

P.M. Plotsky, J.A. Eisler, K.J.S. Anand

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

47

S.24.04 - Effects of differential early social experience on biological and behavioral development in rhesus monkeys

Stephen J. Suomi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

48

S.24.05 - Studies in nonhuman primates provide insights into the dysregulation of emotional responses and psychopathology

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

49

S.25.01 - Evaluating the benefits of antidepressant therapy — Modelling the impact on quality of life

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 315 KB

english, 1996

50

P.6.031 - The effect of chronic naltrexone treatment on hyperactive behaviour in children with autism

S.H.N. Willemsen-Swinkels, J.K. Buitelaar, H. van Engeland

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 170 KB

english, 1996

51

S.25.02 - Controlled trials versus naturalistic studies

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 320 KB

english, 1996

52

S.25.04 - Managed care and antidepressant pharmacotherapy: Economic considerations

L.M. Robinson, D.A. Sclar, T.L. Skaer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

53

S.25.05 - Cost-effectiveness of treatments for schizophrenia

R.W. Kerwin, K.J. Aitchison

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

54

S.26.02 - Is 5HT5D involved in obsessive compulsive disorder?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 323 KB

english, 1996

55

S.26.03 - Neurosurgery for otherwise intractable OCD — An update

P. Mindus, B. Lippitz, S. Andréewitch, H. Nyman, T. Hindmarsh, Chr. Lindquist, B.A. Meyerson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 331 KB

english, 1996

56

S.26.04 - Genetics of the Gilles de la Tourette syndrome and obsessive compulsive disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 170 KB

english, 1996

57

P.3.039 - Regulation of AP-1 transcription complex in the CNS by antipsychotics

P. Rogue, A.N. Malviya, G. Vincendon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

58

P.3.043 - Social functioning and psychopathology of people in long-term psychiatric day care. Influence of new and classical neuroleptics on patient's outcome

S. Nicolaou, G. Fazzari, C. Gozio, R. Este, M. Giuliattini

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 168 KB

english, 1996

59

P.3.044 - Attentional abnormalities in an animal model for developmental disorders of the entorhinal cortex

L.M. Talamini, J. Korf

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

60

P.3.045 - Clozapine treatment and psychosocial rehabilitation on schizophrenia longitudinal study on positive and negative symptoms in neuroleptic non responder patients

S. Marchetti, L. Palagini, P. Pietrini, S. Starnini, L. Giuntoli, A. Parrini, M. Guazzelli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

61

P.3.046 - Effects of clozapine on medial prefrontal cortical cells: A presynaptical hypothesis

G. Gobbi, A. Barbieri, L. Janiri, E. Tempesta, S. D Risio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

62

P.3.026 - The patient under neuroteptic treatment: Study of prescription practice in psychiatry in France

B. Lachaux, C. Gaussares, J.L. Terra

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

63

P.3.027 - Study of maternal influenza during pregnancy as a risk factor in schizophrenia

F. Rouillon, J.M. Azorin, J.M. Cohen, D. Dassa, C. Payan, N. Strub

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 296 KB

english, 1996

64

P.3.028 - Epidemiological study on extrapyramidal side effects with neuroleptics

D. Berardi, A. Giannelli, R. Biscione, M. Dell’Atti, G. Ferrari

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

65

P.3.029 - The safety profile of amisulpride, an “atypical” antipsychotic

C. Favennec, W. Rein, S. Turjanski

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

66

P.3.030 - No evidence of association between dopamine D3 receptor gene and bipolar disorder in a sardinian sample

C. Severino, M.A. Palmas, S. Ruiu, M. Del Zompo, P. Piccardi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

67

P.3.031 - The preclinical profile of an original pyridobenzoxazepine, JL 13

J.-F. Lié, J. Bruhwyler, A.J. Goudie, A. Taylor, J. Damas, J. Delarge, J. Géczy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

68

P.3.032 - Rat tardive dyskinesia is mediated by PI linked D-1 dopamine receptor subtype

H. Rosengarten, A.J. Friedhoff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 318 KB

english, 1996

69

P.3.033 - Immunosuppressive effect of neuroleptic drugs — is it integrated in their antipsychotic action?

I. Leykin, R. Mayer, M. Deckmann, M. Shinitzky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

70

P.6.032 - Hypoxia and hyperventilation as models for cognitive deficiencies

E. Hogervorst, W. Riedel, M. Van Boxtel, J. Jolles

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 170 KB

english, 1996

71

P.3.034 - A polymorphic region in the human tyrosine hydroxylase gene is associated with disturbances of the catecholaminergic system in schizophrenia

F. Thibaut, J.-M. Ribeyre, S. Dollfus, N. Dourmap, R. Meloni, C. Laurent, D. Campion, J. Mallet, M. Petit

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

72

P.3.035 - The effects of benzodiazepines — hypnotics on performance and recent memory during the therapy of isomnia in schizophrenic patients

M. Jasovic-Gasic, G. Nikolic-Balkoski, V. Kuzmanovic, A. Tasic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

73

P.3.036 - Pramipexole as an adjunct to haloperidol in schizophrenia

C. Barnas, A. Heiden, H.P. Volz, G. Laakmannc, H. Zeit, H. Pfolz, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

74

P.3.053 - Detection on 5HT7 receptors using [3H]risperidone: A brain regional distribution

W. Gommeren, P.F.M. Janssen, A. Schotte, J.E. Leysen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

75

P.3.054 - Prevalence of refractory depression and therapeutic strategies in an italian out-patient mental health department

A. Jansen, A. Gademan, A. De Jonge, I. Van Engeland, A. Kahn, M. Gispende-Wied

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

76

P.3.055 - Disturbed stress response in Multiple Complex Developmental Disorder and schizophrenia: Salivary cortisol response to a psychological stressor as a measure

L.M.C. Cittadini, P.J. Figura, R.C.J. Gemignani, H. Guerrini, R.S. Dani, C.C. Guazzelli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

77

P.3.056 - Treatment costs of schizophrenic patients

E. Thys, M. De Hert, J. Peuskens, J. Boydens, K. Kesteloot, P. Gilis, L. Verhaegen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

78

P.3.057 - Stimulation of serotonin (5-HT)1A autoreceptors enhances dopamine (DA) and noradrenaline (NAD) release in rat frontal cortex: influence of S 15535, WAY 100,635 and 8-OH-DPAT

F. Lejeune, A. Gobert, J.-M. Rivet, A. Newman-Tancredi, V. Audinot, M.J. Millan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

79

P.3.058 - A comparison of the incidence of long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol

J.S. Street, R.N. Tamura, T.M. Sanger, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

80

P.3.059 - A comparison of extrapyramidal syndromes between olanzapine and placebo in shcizophrenia

J.S. Street, M. Dellva, R.N. Tamura, T.M. Sanger, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

81

P.3.060 - A comparative in vitro and in vivo characterization of the novel dopamine D3 receptor antagonists, (+)S 14297, nafadotride, GR 103,691 and U 99,194

V. Audinot, L. Gluck, A. Newman-Tancredi, K. Bervoets, I. Deposte, M. Brocco, M.J. Millan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 303 KB

english, 1996

82

P.3.062 - Response to risperidone in schizophrenic in-patients refractory to antipsychotics

D. Bussé, R. Cano, J. Giménez-Salinas, S. Sarró, Ma L. Tiffó

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

83

P.3.063 - Switching from a conventional antipsychotic (haloperidol) to an atypical antipsychotic (‘Seroquel’ ’ ICI 204,636)

J.S.E. Hellewell, B.C. Hurst, C.G.G. Link

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

84

P.3.064 - ‘Seroquel’ (ICI 204,636)-Efficacy in treating the negative symptoms of schizophrenia

B.C. Hurst, C.G.G. Link

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

85

P.4.004 - Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in isolated tissues

A. Capasso, L. Sorrentino

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

86

P.4.006 - Effects of nitric oxide synthase inhibition on ethanol withdrawal syndrome in rats

İ.T. Uzbay, B.F. Erden, B. Sever

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

87

P.4.007 - The involvement of voltage-dependent Ca2+ channel in effects of acutely and chronically administered LSD on biogenic amine metabolism in various areas of rat brain

Lucyna Antkiewicz-Michaluk, Irena Romańska

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

88

P.4.008 - Chronic mild stress causes a decrease in the preference for low ethanol concentrations in male Wistar rats

J.W. Smith, S. Maurel Remy, R. Schreiber, J. De Vry

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

89

P.4.009 - A parametric evaluation of the effects of cyanamide on ethanol intake and preference in rats

S. Maurel Remy, R. de Beun, R. Schreiber, J. De Vry

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

90

P.4.010 - Interferon and interleukin-2 as modulators of alcohol behavioral reactions in C57B1/6 mice

V.G. Fomina, T.V. Davidova, K.D. Pletsityi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

91

P.4.011 - The effect of ACPC, a partial agonist of glycine receptors, on motivational aspects of morphine dependence

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

92

P.4.023 - Different traits of personality and Cloninger's types of alcoholism

A. Hadjichristos, R. Rago, G. Pozzi, S. Fontana, A. Genualdo, L. Janiri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

93

P.6.034 - Serotoninergic activity in eating disorders subtypes

C.E. Ramacciotti, D. Marazziti, L. Guidi, E. Bondi, G. Bertozzi, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

94

P.4.028 - The effect of ethnic belonging of drug addicts on the structure and the treatment period of the abstinent syndrome for some forms of drug addiction

H.A. Krivogornitsina

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

95

P.5.002 - Fluvoxamine in the treatment of obsessive-compulsive disorder: A double-blind comparison with clomipramine

E. Mundo, E. Smeraldi, L. Bellodi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

96

P.5.003 - A comparison of the full 5-HT1A agonist flesinoxan with other 5-HT1A agonists: Effects on behaviour and a quantification of (partial) agonism on cells

J. Mos, E. Ronken, W.C.C. Cramer, e.M. Molewijk, J.A.M. van der Heyden, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

97

P.5.004 - Treatment maintenance time in panic disorder with or without agoraphobia

A. Corominas, J. Vallejo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

98

P.5.005 - A reappraisal of the role of serotonin versus GABAergic interaction in emotional control

M. Nazar, A. Plaznik

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 294 KB

english, 1996

99

P.5.014 - Pharmacological treatment of social phobia: A controlled study with alprozolam and buspirone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

100

P.5.017 - Fluvoxamine for children and adolescents with Obsessive Compulsive Disorder: A controlled multicenter trial

Mark A. Riddle, J. Claghorn, G. Gaffney, J. Greist, D. Holland, R. Landbloom, B. McConville, T. Piggott, M. Pravetz, J. Walkup, Yaryura-Tobias, V. Houser

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

101

P.5.024 - Efficacy of the full 5-HT1A receptor agonist flesinoxan compared with other 5-HT1A agonists in animal models for anxiety

J. Mos, W.C.M. Cramer, J.A.M. van der Heyden, H.E. Molewijk, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 309 KB

english, 1996

102

P.5.025 - Characteristics of patients with a prescription of benzodiazepine

C. Barnas, S. Fröhlich, S. Whithworth, C. Miller, W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

103

P.5.026 - Combination of two SSRI's in long-term treatment of patients with OCD-four case reports

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

104

P.5.028 - Efficacy of different serotonergic drugs in obsessive-compulsive disorder

C. Pfaner, S. Presta, A. Gemignani, A. Milanfranchi, P. Lensi, S. Ravagli, I. Maremmani, D. Marazziti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

105

P.5.028 - Obsessive Compulsive Disorder with episodic course: Is it a mood disorder related subtype?

A. Gemignani, C. Pfanner, S. Presta, A. Milanfranchi, P. Lensi, S. Ravagli, D. Marazziti, I. Maremmani, G. Perugi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

106

P.5.029 - Comorbidity between obsessive compulsive disorder and unipolar and bipolar disorders

C. Pfanner, S. Presta, A. Gemignani, A. Milanfranchi, P. Lensi, S. Ravagli, D. Marazziti, I. Maremmani, G. Perugi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

107

P.5.034 - The effects of meta-chlorophenylpiperazine at cerebral blood flow and behavior in Obsessive Compulsive Disorder (OCD). Is the cerebellum involved in OCD?

K.L. Ho Pian, H.G.M. Westenberg, J.A. den Boer, W.I. De Bruin, P.P. van Rijk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

108

P.5.035 - Characterization of [3H]GR 125,743 as a radioligand at 5-HT1Dreceptors in guinea pig brain: A comparison with [3H]5CT

V. Audinot, S. Lochon, M.J. Millan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

109

P.6.035 - Comparison of brain activity patterns during finger opposition with and without tactile stimulation using a BOLD-fMRI method

J.M. Jansma, N.F. Ramsey, L.J.M. Meinders, W.P.Th.M. Mali, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

110

P.5.036 - Dopaminergic properties of the 5-HT1A receptor antagonists WAY-100,635 and (S)-UH-301

Sven Ahlenius, Ingrid Henriksson, Olle Magnusson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 275 KB

english, 1996

111

P.5.037 - Urinary excretion of cortisol, norepinephrine, epinephrine, testosterone, and melatonin in panic disorder

B. Bandelow, G. Sengos, D. Wedekind, G. Huether, J. Pilz, A. Brooks, G. Hajak, E. Rüther

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

112

P.5.038 - Efficacy measurement with the new panic and agoraphobia scale by using a new nonparametric test for repeated measures

B. Bandelow, E. Brunner, A. Broocks, G. Hajak, D. Beinroth, E. Rüther

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

113

P.5.039 - Panic disorder and agoraphobia: What is effective?

B. Bandelow, K. Sievert, M. Röthemeyer, E. Rüther

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

114

P.5.040 - Treatment outcome in poor metabolizers versus extensive metabolizers in a population of psychotic patients in Denmark and Norway

L. Bjarking, A. Løwert, P.J. Andersen, S. Lindberg, J. Bratholm, J. Berglund, D. Norum, T.S. Hansen, L. Bayer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

115

P.5.041 - The evaluation of fluvoxamine in the treatment of social phobia

C.L. DeVane, M.R. Ware, N.P. Emmanual, O. Brawman-Mintzer, R.B. Lydiard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

116

P.6.009 - The effects of delta sleep inducing peptide on burying behavior in rats with active and passive behavioral strategies

T.V. Strekalova

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

117

P.6.011 - Psychiatric and psychosocial assessment of deliberate self-mutulation in: A controlled study

M. Çetin, A. Özçubukçuoğlu, N. Tarhan, L. Şenyüz, Y. Burkovik

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 300 KB

english, 1996

118

P.6.012 - Expression of IL-6 receptor mRNA in the hypothalamus of restrained rat

T. Komori, R. Fujiwara, K. Shizuya, J. Nomura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

119

P.6.013 - CNS depressant effects of olfactory stimulation in rats

T. Komori, M. Tanida, A. Kikuchi, K. Shoji, S. Nakamura, J. Nomura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

120

P.6.014 - Cholecystokinin peptides in cerebrospinal fluid: Findings in healthy male volunteers

T. Gunnarsson, T. Eklundh, M. Eriksson, S. Sjöberg, C. Nordin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

121

P.6.015 - The role of nitric oxide in chemically and electrically induced convulsions in mice

E. Przegaliński, L. Baran, J. Siwanowicz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

122

P.6.016 - ERP waves of ADHD- and normal control children in a continuous performance test

C.C.E. Overtoom, C. Kemner, H.S. Koelega, J.K. Buitelaar, R.J. van der Gaag, H. van Engeland, M.N. Verbaten

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

123

P.6.017 - Pharmacokinetic-pharmacodynamic modelling of the interaction between phenytoin and sodium valproate

O.E. Della Paschoa, R.A. Voskuyl, M. Danhof

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

124

P.6.018 - Assessment of the pharmacodynamic interaction between phenytoin and sodium valproate by ictal behaviour analysis

O.E. Della Paschoa, R. Hamstra, R.A. Voskuyl, M.R. Kruk, M. Danhof

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

125

P.6.019 - New therapeutic strategy for migraine treatment: Desensitization with a dopamine agonist

M. Lai, A. Cherchi, V. Loi, M. Del Zompo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

126

P.6.020 - Use of psychotropic medication before and after psychotherapeutic inpatient treatment

G. Laux, U. Mey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 316 KB

english, 1996

127

P.6.021 - Effects of sex and aging on 3H-paroxetine binding to human platelets

D. Marazziti, A. Rossi, L. Palego, G. Giannaccini, A. Lucacchini, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

128

P.6.022 - Histamine mediates long-term potentiation of excitability in rat hippocampus

O. Selbach, H.L. Haas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 305 KB

english, 1996

129

P.6.023 - Acute tyrosine depletion reduces catecholamine synthesis in the rat brain

S.F.B. McTavish, P.J. Cowen, T. Sharp

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

130

P.6.024 - Risperidone in the treatment of Gilles de la Tourette Syndrome

M. Stamenkovic, S. Schindler, H.N. Aschauer, s. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

131

P.6.025 - Morphine counteracts the effects of juvenile isolation on later social behaviour

C.L. van den Berg, J.M. Van Ree, B.M. Spruijt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 300 KB

english, 1996

132

P.1.011 - Clinical profile of mirtazapine

M. van Moffaert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

133

P.1.012 - Pharmacokinetics and relevance for choice

L.P.C. Delbressine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

134

P.1.013 - Mental retardation: Effectiveness of fluvoxamine in the treatment of depressive symptoms: Case reports

A. Lenzi, T.F. Rastelli, I. Bianco, C.L. Gianfranchi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

135

P.1.014 - Risperidone in the treatment of rapid cycling bipolar disorder

E. Vieta, C. Gastó, A. Otero, J. Vallejo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 296 KB

english, 1996

136

P.6.036 - Therapeutical approaches to sexual disadaptation

N.D. Kibrik, J.A. Reshetnyak

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

137

P.1.015 - The safety profile of fluvoxamine in elderly patients

W. Wagner, V. Hauser, L.F. Wong

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

138

P.1.016 - Fluvoxamine effective in preventing recurrence of major depression

J.L. Terra, F. Noël

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

139

P.1.017 - The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects

K. Puechler, K. Schaffler, C.-H. Wauschkuhn, A. Plenker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

140

P.1.018 - The safety and tolerability profile of a new RIMA antidepressant, RS-8359 in healthy subjects and depressed patients

K. Puechler, A. Plenker, H.-P. Volz, P.U. Witte

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

141

P.1.023 - Synergistic increases of noradrenaline and 5-HT neurotransmission induced by milnacipran with pindolo

C. Moret, M. Briley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

142

P.1.025 - Flesinoxan: microdialytic profiling of a 5-HT1A receptor agonist

J.A.M. van der Heyden, A.I. Bosch, E.J. de Rond, S.K. Long

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

143

P.1.026 - Prolactin and TSH responses to TRH and to ECT in pre- and post-menopausal women with major depression

E. Lykouras, M. Markianos, C. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

144

P.1.027 - Treatment of sleep disturbance and pain syndrome in fibromyalgia patients with the 5-HT2-receptor antagonist ketanserine

U. Hemmeter, R. Kocher, M. Hatzinger, E. Seifritz, R. Bischof, C.J. Lauer, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

145

P.1.028 - The Vienna outpatient-clinic for therapy-resistant depression

G. Lenz, U. Bailer, M. Serim, C. Schumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 294 KB

english, 1996

146

P.1.029 - Antidepressant effects of tianeptine, of its two enantiomers and its predominant metabolite in the learned helplessness test in rats

P. Lacroix, N. Rocher, A. Deslandes

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

147

P.1.030 - The effect of antimanic drugs on the hypermotility response to intracerebroventricular administration of ouabain in the rat

D.C. Piper, D.A. Cooper, N. Upton

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

148

P.1.031 - Localization of 5HT1Dα-and 5HT1Dβ-receptor mRNA by in situ hybridization in guinea pig brain and trigeminal ganglia

P. Bonaventure, P. Voorn, W.H.M.L. Luyten, A. Schotte, J.E. Leysen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

149

P.1.042 - Clinical relevence of antibodies against serotonin and gangliosides, and acute phase proteins in major depression

A. Sluzewska, W. Samborski, M. Sobieska, R. Klein

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

150

P.1.043 - Toxicity of antidepressant drugs: A comparative in vitro study

S. Lisch, F. Holsboer, C. Behl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

151

P.1.044 - Effects of selective serotonin reuptake inhibitors given repeatedly on 5-HT receptor subpopulations in the rat brain

J. Maj, M. Dziedzicka-Wasylewska, V. Klimek, E. Moryl, Z. Rogóż, G. Skuza

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

152

P.1.045 - Flesinoxan, a selective 5-HT1A receptor agonist, familiarizes with fluvoxamine and fluoxetine in a conditioned taste aversion procedure in mice

J.A. Bouwknecht, J. Gommans, T.H. Hijzen, H.H.G. Berendsen, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

153

P.1.047 - Comparison of amisulpride and seelctive serotonine reuptake inhibitors efficacy on cognitive and anxious symptoms in dysthymic disorder

M. Scotta, V. Fonzo, P. Rocca, E. Zanalda, L. Ravizza

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

154

S.07.05 - PANDAS: Pediatric autoimmune neuropsychiatric disorders associated with strep — is this a new species of childhood-onset obsessive-compulsive disorder and tourette's syndrome?

S.E. Swedo, H.L. Leonard, M.A. Garvey, B.B. Mittleman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

155

S.07.02 - The place of cognitive therapy in the treatment of obsessive compulsive disorder

P. van Oppen, A.J.L.M. van Balkom, E. de Haan, P. Spinhoven, C.A.L. Hoogduin, R. van Dyck

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

156

S.07.01 - Natural course of OCD

L. Ravizza, G. Barzega, S. Bellino, F. Bogetto, G. Maina

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 138 KB

english, 1996

157

P.3.021 - Chronic immunological process in schizophrenia

A. Sluzewska, J.K. Rybakowski, M. Sobieska, M. Linka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

158

P.6.033 - Effectiveness of pemoline among hyperkinetic children who fail to respond to methylphenidate

B.G. Winsberg, S. Klee, J. Pollack

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 170 KB

english, 1996

159

P.3.022 - Hydroxylation polymorphism of debrisoquin hydroxylase (CYP2D6) in a population of psychotic patients in Norway and Denmark

A.A. Dahl, S. Asserson, M. Fogh, F. Kristensen, O.G. Nyquist, S. Tønseth, E. Mæ

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

160

P.3.020 - Functional hypofrontality revealed by EEG coherence analysis of 16 antipsychotic-free schizophrenic patients performing cognitive activation paradigms

J. Tauscher, P. Rappelsberger, A. Neumeister, P. Fischer, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

161

P.3.018 - Clozapine in refractory schizophrenic disorders: A longitudinal study of efficiency, tolerability and clinical improvement during a period up to four years

L. Maître, N. Poisson, F. Gekiere, M.C. Dessalles, J. Bouchez, V. Guérin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

162

P.3.015 - Amisulpride in the treatment of deficit schizophrenia

W. Rein, O. Fleurot, S. Turjanski

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

163

P.3.016 - Olanzapine in the treatment of schizoaffective disorder

Y. Lu, T. Sanger, C. Beasley, P. Tran, G. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

164

P.3.014 - Amisulpride in the treatment of productive schizophrenia

W. Rein, S. Turjanski, O. Fleurot

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 300 KB

english, 1996

165

P.3.012 - Combined use of carbamazepine and valproic acid in negative symptom schizophrenia

Lee Min-Soo, Choi Byung-Hoon, Kim Seung-Hyun

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

166

P.3.013 - Comorbid mood disturbance in schizophrenia

G.D. Tollefson, Y. Lu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

167

P.3.010 - Treating poor prognosis schizophrenia

A. Chinchilla Moreno, M. Vega Piñero, J.J. Padín Calo, A. Cebollada Gracia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 296 KB

english, 1996

168

P.3.008 - Dopaminergic and nicotinic interactions in the human striatum in dementia with lewy bodies, chronic schizophrenia and Parkinson's disease

M.A. Piggott, J.A. Court, E.K. Perry, S. Lloyd, N.J. Thomas, Z.M. Smith, M. Johnson, R.H. Perry, I.G. McKeith

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

169

P.3.009 - Risperidone treatment of schizophrenia: Clinical experience

C. Spisla, D. Baciu, M. Bünter, U. Billeter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

170

P.3.007 - Lack of interaction between amisulpride and lorazepam on psychomotor performance and memory in healthy volunteers

M.C. Perault, L. Bergougnan, A. Paillat, C. Gomeni, I. Zieleniuk, B. Vandel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 306 KB

english, 1996

171

P.3.006 - Event-related potentials and selective auditory and visual attention in autism

M.R. Hoeksma, C. Kemner, M.N. Verbaten, H. Van Engeland

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

172

P.3.005 - D2 dopamine receptor occupancy (IBZM-SPECT) and extrapyramidal symptoms under treatment with risperidone

T. Mager, I. Dähne, S. Dresel, F. Pajonk, K. Tatsch, H.J. Möller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 302 KB

english, 1996

173

P.3.002 - Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects

B.N.M. van Berckel, C. Lipsch, S. Timp, C. Gispen-de Wied, H. Wynne, J.M. van Ree, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

174

P.3.003 - Case-control and neuro-imaging study in persons with schizophrenia after prenatal exposure to the Dutch Famine in 1945

J.S. Kalkman, H.W. Hoek, E.S. Susser, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

175

P.3.004 - Optimized analysis of the D2 dopamine receptor occupancy by image fusion of corresponding I-123 IBZM-SPECT and MR-DATA

T. Mager, S. Dresel, K. Tatsch, T. Pfluger, H.-J. Möller, K. Hahn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

176

P.2.019 - Amiridin efficacy in Alzheimer's disease and multi-infarct dementia: The resemblance and the distinction

E.E. Bukatina, I.V. Grygorieva, O.R. Smirnov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

177

P.3.001 - Phencyclidine (PCP) alters excitability in CA1 hippocampal neurons by inhibiting local circuit inhibition and increasing transmembraneous calcium influx

H. Grunze, E. Hearn, D. Rainnie, M. Berger, R. McCarley, R. Greene

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

178

P.2.018 - Reduced Gs protein function and Gαs levels in leukocytes of patients with Parkinson's disease

L. Barki-Harrington, S. Avissar, Y. Herishanu, G. Schreiber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

179

P.2.016 - Investigation of the selectivity of vesamicol analogues as markers for cholinergic neurons: Potential ligands for single photon emission computerized tomography (SPECT) in Alzherimer's disease

F.G.J. Custers, J.D.M. Herscheid, J.C. Stoof, J.E. Leysen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

180

P.2.017 - Novel substituted acyl-prolyl dipeptide, GVS-111, diminishes cognitive impairment on the model of ischemic stroke in rats

G.A. Romanova, R.U. Ostrovskaya, T.A. Gudasheva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

181

P.2.015 - H1-blockers induce deficit in active and passive avoidance performance in rats

V. Georgieva, S. Todorov, M. Lazarova-Bakarova

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

182

P.2.013 - Neuro-immuno-pharmacological effects of flobufen in model experiments with aging rats

O. Benešová, H. Tejkalová, V. Panajotovová, Z. Krištofiková, P. Hušek, J. Klaschka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

183

P.2.014 - Risperidone is well tolerated by organic brain syndromes

E. Pourcher, R.H. Bouchard, F. Chassé

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

184

P.2.012 - Maintenance of calcium-mediated metabolic control as a therapeutic principle in energy-compromised neurological disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 300 KB

english, 1996

185

P.2.011 - Long-acting neuroleptics treatment of patients in residential rehabilitation programs

L. Codazzi, A. Giannelli, M. Rabboni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

186

P.2.012 - Maintenance of calcium-mediated metabolic control as a therapeutic principle in energy-compromised neurological disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

187

P.2.010 - Thrombocyte phenolsulphotransferase and monoamine oxidase activity, and benzodiazepine binding in patients with dementia of Alzheimer type

P. Bongioanni, F. Gemignani, M. Castagna, B. Boccardi, M. Ronato

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 302 KB

english, 1996

188

P.2.009 - Thrombocyte monoamine oxidase molecular activity in demented and parkinsonian patients

P. Bongioanni, C. Mondino, M. Borgna, F. Gemignani

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

189

P.2.008 - Benzodiazepine binding in T-lymphocytes from parkinsonian patients

P. Bongioanni, M. Castagna, F. Gemignani, C. Mondino

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 306 KB

english, 1996

190

P.1.081 - Forskolin effects on behavior in rats and in depressed and schizophrenic patients

Yuly Bersudsky, Yardena Patishi, Marina Shifrina, Moshe Kotler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

191

P.1.080 - Antidepressants combined with acupuncture in therapy of endogenous depressions

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

192

P.1.074 - Potentiation of antidepressants with lithium or carbamazepine

A. Suwalska, J. Rybakowski

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

193

P.1.075 - Mianserin therapy of depressive patients with coexisting cardiovascular diseases

Jolanta Rajewska, Andrzej Rajewski

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

194

P.1.073 - Prolyl-leucyl-glycinamide, thyrotropin releasing hormone and β-endorphin-(10–16), like antidepressants, inhibit the effects of melatonin on rat behaviour

G. Wolterink, K. Hatta, J.M. Van Ree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 256 KB

english, 1996

195

P.1.072 - Plasma arginine vasopressin and motor activity in patients with major depression and in healthy controls

L. van Londen, G.A. Kerkhof, F. van den Berg, J.G. Goekoop, A.H. Zwinderman, J.C. Frankhuijzen-Sierevogel, V.M. Wiegant, D. de Wied

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 106 KB

english, 1996

196

P.1.070 - Antidepressant profile of the 5-HT1A agonist Flesinoxan in various forced-swim test paradigms

J.A.M. van der Heyden, J. Mos, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 252 KB

english, 1996

197

P.1.068 - The treatment of dysthymic patients: Fluvoxamine versus amitriptyline

Mario Amore, Manuela Ricci, Nicoletta Zazzeri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

198

P.1.069 - A drug discrimination rocedure in the pigeon confirms the in vitro agonistic action of flesinoxan on the 5-HT1A receptor

A.H.J. Herremans, J.A.M. van der Heyden, E. Ronken, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

199

P.1.066 - Association study of bipolar disorder and a serotonin receptor polymorphism

B. Mahieu, D. Souery, O. Lipp, V. Demaertelaere, C. Van Broeckhoven, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

200

P.6.030 - Effects of vasopressin metabolites on social recognition in the rat

L.G.J.E. Reijmers, J.P.H. Burbach, B.M. Spruijt, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 307 KB

english, 1996

201

P.1.067 - Thyroid function and seizure time during ECT

Y. Papakostas, M. Markianos, A. Pehlivanidis, G.N. Papadimitriou, I.M. Zervas, M. Daras, M. Theodoropoulou, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

202

P.1.065 - Increased D2/D3 dopamine receptor binding associated with pharmacotherapy response before and after treatment of major depression measured by single photon emission computed tomography (SPECT)

A. Klimke, R. Larisch, S. Löffler, H. Vosberg, H.W. Müller-Gärtner, W. Gaebel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

203

P.1.064 - Responsiveness of rabbit prostate strips to imipramine and trazodone

B. Tita, P. Bolle, C. Baldazzi, M.L. Casini, P. Faccendini, P. Faticanti, P. Tucci

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

204

P.1.063 - Responsiveness of rabbit detrusor, urethra, and trigone strips to imipramine and trazodone

B. Tita, P. Bolle, C. Baldazzi, M.L. Casini, P. Faccendini, P. Faticanti, P. Tucci

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 307 KB

english, 1996

205

P.1.061 - Clinical differences in response to mianserin and fluvoxamine in depressive patients

F. Lavergne, I. Berlin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

206

P.1.062 - Stimulus properties of mirtazapine resemble those of a 5-HT1A receptor agonist

H.H.G. Berendsen, C.L.E. Broekkamp

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

207

P.1.060 - Pharmacology of the presynaptic terminal: Modifications induced by antidepressant treatment in the phosphorylation of synaptotagmin and its functional properties

M. Popoli, A. Venegoni, L. Buffa, G. Racagni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

208

P.1.059 - The presynaptic release apparatus: A main site in the mechanism of action of psychotropic drugs

M. Popoli, C. Vocaturo, L. Buffa, A. Venegoni, J. Perez, G. Racagni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

209

P.1.041 - Antibodies against serotonin and gangliosides in fibromyalgia and major depression

W. Samborski, A. Sluzewska, R. Klein, M. Sobieska, J. Lecki, T. Stratz, W. Mueller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

210

P.1.039 - Fluvoxamine versus desipramine in elderly patients with major depression: A double-blind comparison

M. Tourigny-Rivard, N.P.V. Nair, P. Vincent

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

211

P.1.040 - Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist in the forced swimming test in rats

A. Dereń-Wesołek, E. Tatarczyńska, E. Przegaliński, E. Chojnacka-Wójcik

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

212

P.1.038 - Therapeutic monitoring of amitriptyline, fluvoxamine and lithium in depressed patients on combined therapy

B. Miljković, M. Pokrajac, I. Timotijević, V. Varagić

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

213

P.1.036 - Flesinoxan in the treatment of major depressive disorder: A fixed dose, placebo-controlled trial

C. Prinsze, G. Stevens

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

214

P.1.037 - Clinical and neuroendocrine response to fluvoxamine treatment in impulsive borderline personality disorder

Th. Rinne, E. Gans, R. Vernimmen, J.A. den Boer, H.G.M. Westenberg, W. van Tilburg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

215

P.1.034 - Antidepressant therapy and dopamine D2 receptors measured with SPECT

H. D’haenen, D. Steenssens, F. Flamen, H. Everaert, A. Bossuyt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

216

P.1.035 - Tolerance and therapeutic response of paroxetine in the depressed elderly

I. De la Serna, A. Fernandez Camacho

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

217

P.1.033 - Efficacy and safety of fluoxetine in major depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 293 KB

english, 1996

218

P.1.032 - Selective serotonin reuptake inhibitors: Adverse drug reactions registered by SANZ-Swiss spontaneous reporting system

C. Spisla, M. Bünter, K. Hartmann, M. Kuhn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

219

P.1.024 - Milnacipran, a double noradrenaline and 5-HT reuptake inhibiting antidepressant increases cerebral extracellular monoamine levels

C. Moret, M. Briley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

220

P.1.021 - Low serum cholesterol, serotonin and suicidal behavior

W. Pitchot, B. Hild, M. Ansseau

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

221

P.1.022 - Platelet serotonin, 3H-paroxetine binding and recurrent suicide attempts: A one-year follow up study

R.J. Verkes, D. Fekkes, M.V. Hengeveld, R.C. Van der Mast, J.P. Tuyl, G.M.J. Van Kempen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

222

P.1.020 - Serotonergic mechanisms in the pathophysiology of seasonal affective disorder

A. Neumeister, N. Praschak-Rieder, B. Hesselmann, M. Rauh, A. Barocka, O. Vitouch, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

223

P.1.019 - The effects of a new RIMA antidepressant RS-8359 on cardiovascular function

K. Puechler, A. Plenker, H.-P. Volz, P.U. Witte

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

224

P.1.009 - Characterization and inhibition of human cytochrome P-450 enzymes involved in the in vitro metabolism of mirtazapine

C.H.J. Verhoeven, R.M.E. Vos, J.J.P. Bogaards

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

225

P.1.010 - Pharmacology and the relevance for choice

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

226

P.6.028 - The opinion about mental illness, with respect to general psychopathology and personality characteristics, in a sample of subjects of a small greek island

G. Trikkas, K. Zafirakopoulou

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

227

P.1.008 - Mirtazapine versus tricyclic antidepressants in the treatment of severely depressed patients

M. Zivkov, A. Mühring, C.M.E. Kremer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 307 KB

english, 1996

228

P.1.005 - Mirtazapine versus tricyclic antidepressants: An overview of efficacy data

J.M.A. Sitsen, C.M.E. Kremer, H. Slinning, J.T. Helsdingen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

229

P.1.006 - Safety of mirtazapine in overdose

M. Zivkov, C.M.E. Kremer, M.J.A.J.M. Hoes, E. Blokland, J.T. Helsdingen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

230

P.1.007 - Efficacy of mirtazapine in moderate and severe depression

R.M. Pinder, C.M.E. Kremer, M. Zivkov, J.T. Helsdingen, E. Blokland

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

231

P.1.004 - Lack of typical SSRI-related adverse effects and sexual dysfunction with mirtazapine is related to specific blockade of 5-HT2 and 5-HT3 receptors

T. Klint, J.T. Helsdingen, C.M.E. Kremer, M. Zivkov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

232

P.1.001 - Fluvoxamine augmentation in citalopram non-responders: A pharmacokinetic and clinical study

G. Bondolfi, C. Chautems, P. Baumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

233

P.1.002 - Patterns of mood improvement with mirtazapine

C.M.E. Kremer, M. Zivkov, J.T. Helsdingen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

234

P.1.003 - Efficacy of mirtazapine vs clomipramine in severely depressed, hospitalized patients

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

235

S.28.01 - Prodromes of schizophrenia

K. Maurer, H. Hôfner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 259 KB

english, 1996

236

S.27.04 - Gene-environment interactions in complex psychiatric disorders

F. Macciardi, M.C. Cavallini, C. Namia, S. Bossi, G. Cauli, L. Franchini, M. Verga, A. Serretti, A. Morabito, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

237

S.27.03 - Anticipation and dynamic mutations in psychiatry

D. Souery, O. Lipp, B. Mahieu, C. Van Broeckhoven, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

238

S.27.02 - New molecular genetic studies in affective disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

239

S.27.01 - Finding susceptibility genes for schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

240

S.26.05 - Neuroimaging studies in children with Tourette syndrome and obsessive-comlpulsive disorder

J.K. Buitelaar, W.I. de Bruin, P.P. van Rijk, H. van Engeland

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 316 KB

english, 1996

241

P.6.010 - Biochemical and neuroendocrinergic indicators of aggressive behavior: A controlled study

M. Çetin, Ş. Çilden, Y. Burkovik

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

242

P.6.008 - Role of noradrenergic, dopaminergic, serotonergic and opioidergic systems on the effect of neonatal handling in learned helplessness

P. Tejedor-Real, C. Costela, J.A. Micó, J. Gibert-Rahola

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 313 KB

english, 1996

243

P.6.007 - Effects of repeated administration of desipramine and fluoxetine on vasopressin-induced grooming in rats

S. Lightowler, T.P. Blackburn, G.A. Kennett

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

244

P.6.006 - The analgetic activity of the new analog of ACTH (4–) fragment in patients with migraine attack

V.A. Dubinin, M.V. Koroleva, E.E. Meyzerov, N.G. Levitskaya, V.N. Nezavibatko, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 314 KB

english, 1996

245

P.6.029 - GABA-A receptor antagonists: Sex differences in pharmacokinetics and/or pharmacodynamics?

D. Peričić, M. Bujas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

246

P.6.004 - Attentional capacity in normal control and ADHD children, a probe ERP study

L.M. Jonkman, C. Kemner, M.N. Verbaten, H. van Engeland, H.S. Koelega, G. Camfferman, J.K. Buitelaar

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

247

P.6.005 - Eye movements of autistic children

J.N. van der Geest, C. Kemner, H. van Engeland, M.N. Verbaten

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

248

P.6.003 - A comparison of zolpidem and temazepam in psychophysiological insomniacs

G.A. Kerkhof, B.G. van Vianen, H.A.C. Kamphuisen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 310 KB

english, 1996

249

P.6.002 - Lamotrigine may limit pathological excitation by modulating calcium- and potassium currents

H. Grunze, J.V. Wegerer, J. Walden

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

250

P.6.001 - The development of home-seeking behavior in rat pups

Hein O. Sigling, Willem-Hendrik Gispen, Herman van Engeland, Berry M. Spruijt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

251

P.5.043 - Serotonin depletion affects both motor and anti-conflict effects of competitive and noncompetitive NMDA receptor antagonists

M. Jessa, A. Plaznik

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

252

P.5.042 - Intracerebroventricular (icv) administration of CCK-antisense oligodeoxynucleotides prevent anxiety-behavior in rats

H. Cohen, Z. Kaplan, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

253

P.5.033 - EEG abnormalities in anxiety disorders

R. Brezezinski, M. Dabkowski, A. Araszkiewicz, J. Uziallo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 295 KB

english, 1996

254

P.5.030 - The effect of the neuroactive steroid α-THDOC, on staircase test behavior in mice

R. Weizman, Y. Peter, J. Terker, M. Gavish, C.G. Pick

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

255

P.5.031 - Pharmaco-psychological effects of S(+) DN-3227 enantiomer and DN-2327 racemate

B. Dietrich, G. Pabst

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

256

P.5.032 - Clinical effects of buspirone in social phobia, a double-blind placebo controlled study

I.M. van Vliet, J.A. den Boer, H.G.M. Westenberg, K.L. Ho Pian

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

257

P.5.023 - Effect of flesinoxan on the electrocorticogram of the rat

H. Nievelstein, F. Krijzer, J. van der Heijden, B. Oliver

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

258

P.5.022 - Fluoxetine treatment of comorbid premature ejaculation and panic disorder

S. Kindler, O.T. Dolberg, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 313 KB

english, 1996

259

P.5.020 - Repeated flesinoxan administration in rats: Dissociation of hormonal and behavioural effects

L. Groenink, J. van der Gugten, B. Oliver

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

260

P.5.021 - Monoaminergic systems in patients with Obsessive-Compulsive Disorder (OCD) before and after fluoxetine treatment

P. Prolo, U. Albert, G. Maina, L. Ravizza, F. Bogetto, C. Abrigo, M.C. Gennaro, P. Franttini, G. Santagostino

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

261

P.5.019 - Anxiolytic effects found in the fear-potentiated startle response paradigm are not due to a non-specific disruption of startle behavior

R.J.E. Joordens, T.H. Hijzen, B. Oliver

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 309 KB

english, 1996

262

P.5.018 - Discrimination between the 5-HT1 receptor agonists flesinoxan and eltoprazine

J. Gommans, T.H. Hijzen, R.A. Maes, B. Oliver

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

263

P.5.015 - Flesinoxan treatment of Generalized Anxiety Disorder: A fixed dose, placebo-controlled trial

F. Noël, G. Stevens, D. Bradford

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

264

P.5.016 - Correlates and course of irritability and disinhibition during alprazolam treatment of panic disorder

Vladan Starcevic, Katarina Kelin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

265

P.6.027 - Ferment status of lymphocytes in children born by parents with psychic diseases

L.N. Ternovsky, V.A. Ternovskaya, R.P. Nartsissov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

266

P.5.013 - Safety profile of flesinoxan; results form a meta-analysis of studies in patients with major depressive disorder or generalised anxiety disorder

J.M. de Voogd, G. Stevens

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 259 KB

english, 1996

267

P.5.011 - Pharmacotherapy and brief dynamic psychotherapy of panic disorder

A.A. Dahl, I.M. Wiborg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 108 KB

english, 1996

268

P.5.010 - Fluoxetine treatment of children and adolescents with obsessive-compulsive disorders: A open-label trial

Z.B. Baysal, F. Ünal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 258 KB

english, 1996

269

P.5.008 - A new method to quantify effects of benzodiazepines on normal daily activities: Ambulatory accelerometry in psychopharmacological research

J.H.M. Tulen, J.B.J. Bussmann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

270

P.5.009 - Sympatho-adrenomedullary activity during mental stress and orthostatic challenge: Effects of alprozolam and lorazepam

J.H.M. Tulen, F. Boomsma, L. Pepplinkhuizen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

271

P.5.006 - Flesinoxan in generalised anxiety disorder: A meta-analysis of two double-blind, placebo-controlled comparisons with alprazolam

J.M. de Voogd, S.J. van den Berg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

272

P.5.007 - Long-term effects of alprazolam on memory: A 3 1/2 year follow up of agoraphobic patients

C. Kiliç, V.C. Curran, H. Noshirvani, M. Başoğlu, I.M. Marks

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

273

P.5.001 - The relevance of prolonged aversive stimulation stress model for the research of anxious and depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

274

P.4.027 - Preliminary findings on the role of fluvoxamine in the treatment of alcoholism

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

275

P.4.026 - Increased oxidative stress in alcohol dependent patients as estimated by the in vivo acetylsalicylic acid assay (ASAA)

J. Thome, M. Gerlach, J. Zhang, E. Davids, P. Foley, N. Wodarz, G.A. Wiesbeck, J. Böning, P. Riederer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

276

P.4.024 - Treatment of inhalation toxicomania with phenothiazine piperazine derivatives (PPD)

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

277

P.4.025 - Survival analysis of patients with one vs. multiple treatment attempts in a naltrexone program

E. Ochoa, E. Baca-García

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

278

P.4.022 - Codependecy and personality traits in alcoholics and their partners

L. Janiri, M. Onni, A. Hadjichristos, R. Rago, M. Sarchiapone, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

279

P.4.020 - Cloning and characterization of a rat μ-opioid receptor isoform (rMOR1B)

A. Zimprich, J. Kraus, P. Mayer, V. Völlt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

280

P.4.021 - Results of cognitive-behavioral therapy supported by piracetam and computerized cognitive skills (re)training in alcoholics

P. Schett, R. Haller, H. Hinterhuber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

281

P.4.018 - Depression and false depression in alcoholism: An application of brain mapping

A. Garrido, J. Cabanyes

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

282

P.4.019 - Neuroendocrine effects of methylenedioxyethylamphetamine (MDE) in healthy volunteers: Preliminary results of an ongoing human experimental study

E. Gouzoulis-Mayfrank, B. Thelen, E. Habermeyer, A. Kock, H. Sass

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

283

P.4.017 - Trazodone versus clonidine in rapid detoxification from opiates

G.L. Conte, G. Scetta, K. Moscianese, G. Pozzi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

284

P.4.015 - EEG and event related potentials as indicators of central neurophysiological effects of acamprosate

J. Gallinat, U. Hegerl, H.-J. Möller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

285

P.4.016 - Effects of μ and κ opioid agonists on the cholecystokinin-induced activation of opioid system in isolated guinea-pig ileum

L. Romanelli, P. Valeri, M.C. Amico, F. Mattioli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

286

S.01.03 - Does severe depression have a different pharmacology?

H.N. Aschauer, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 254 KB

english, 1996

287

L.3 - Receptors for ATP: New structures and new therapeutic targets

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 116 KB

english, 1996

288

S.04.03 - Novel neuroprotective strategies based on the enhancement of brain kynurenic acid levels

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

289

S.04.01 - Metabotropic receptors and their involvement in cell death

M. Pizzi, P. Galli, O. Consolandi, F. Boroni, S. Gavazova, M. Benarese, M. Memo, P.F. Spano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

290

S.03.05 - Event related potentials as indicators of central serotonergic activity

U. Hegerl, G. Juckel, H.-J. Möller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 319 KB

english, 1996

291

S.03.04 - Magnetoencephalography (MEG) in the study of human brain functions

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 169 KB

english, 1996

292

S.03.03 - Studies of cerebral blood flow with SPET and PET — Promises and pitfalls

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

293

S.03.02 - PET studies on the dopamine system in vivo

L. Farde, N. Ginovart, C. Halldin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

294

S.03.01 - Functional magnetic resonance imaging as a research tool: Quality assessment of PRESTO, a non-invasive three-dimensional imaging technique

N.F. Ramsey, P. van Gelderen, K. Tallent, J.H. Callicott, C.T.W. Moonen, D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

295

S.02.05 - Acamprosate and relapse prevention: Results from a pooled analysis of 11 randomised placebo-controlled trials in 3338 alcohol-dependent patients

H. Sass, A.S. Potgieter, Ph. Lehert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

296

S.02.04 - Opiate antagonists in the treatment of alcohol dependence: Results of a UK study

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 319 KB

english, 1996

297

S.02.03 - Endorphins and experimental drug addiction

M.A.F.M. Gerrits, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 316 KB

english, 1996

298

S.02.02 - Involvement of corticotropin-releasing factor in addiction

S.C. Heinrichs, S. Rassnick, G. Schulteis, F. Menzaghi, E. Merlo Pich, R. Richter, F. Weiss, G.F. Koob

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

299

S.02.01 - Modulation of drug reward by receptor ligands

E. Zvartau, A. Bespalov, A. Kuzmin, N. Patkina, S. Semenova

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 305 KB

english, 1996

300

L.2 - Personality disorders are disorders of the personality

J.J. López-Ibor Jr.

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 251 KB

english, 1996

301

L.1 - Neuroendocrine studies in depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

302

S.01.04 - Adjunctive therapy in severe depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

303

P.4.014 - Clozapine treatment of severe tardive dystonia

R. Cavallaro, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 283 KB

english, 1996

304

P.4.013 - 5-HT2 blocker ritancerin attenuates the behavioral expression of precipitated morphine abstinence

M.F. Kudryashova, E.V. Verbitskaya

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

305

P.4.012 - Is anhedonia a predictive factor for relapse in alcohol dependence?

D. Marra, D. Warot, C. Payan, E. Hispard, S. Dally, A.J. Puech

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

306

P.4.005 - Antibodies to serotonin and cathecholamines as neuroimmunumodulators in experimental opiate addiction

L.A. Basharova, V.A. Evseyev, N.A. Trekova, L.A. Vetrile

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

307

P.4.003 - Cortisol and temperature responses to flesinoxan in alcoholism

W. Pitchot, M. Ansseau, M. Hansenne, V. Barbier, A. Gonzalez Moreno

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 300 KB

english, 1996

308

P.4.001 - Abnormal regional cerebral blood flow in opioid dependent patients

G. Fischer, K. Diamant, L. Pezawas, S. Schindler, I. Podreka, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

309

P.4.002 - Norharman in multiple drug-addicts and healthy controls

D. Fekkes, L. Timmerman, G.J. van Gelderen, L. Pepplinkhuizen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

310

P.3.076 - Effect of plasmapheresis in the treatment of drug-resistant schizophrenic patients with biochemical and immunological control

D.I. Malin, M.G. Uzbekov, E.Y. Misionzhnic, I.V. Domashneva, S.S. Neduva, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 306 KB

english, 1996

311

P.3.074 - Peculiarifies of psychopharmacotherapy for prolonged depressive-delusional states with resistance phenomena

I.N. Emelyanova

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

312

P.3.075 - Effect of long-term maintenance psychotropic therapy on occupational adaptation of schizophrenic patients

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 163 KB

english, 1996

313

P.3.073 - Enzymes of the antioxidant system in Type I schizophrenia

C.D. Miljevic, A. Nikolic, A. Damjanovic, Z. Saicic, M.B. Spasic, V.R. Paunovic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 315 KB

english, 1996

314

P.3.067 - Reduction of the positive symptoms of schizophrenia by ‘Seroquel’ (ICI 204,636): Results from phase II and III clinical trials

W.W. Hong, L.A. Arvanitis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

315

P.3.068 - The atypical profile of ‘Seroquel’ (ICI 204,636) is supported by its lack of inductionof extrapyramidal symptoms

W.W. Hong, L.A. Arvanitis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

316

P.3.069 - The safety of ‘Seroquel’ (ICI 204,636) in the treatment of elderly subjects with psychotic disorders

W.W. Hong, L.A. Arvanitis, P.T. Thyrum, Y.W.J. Wong

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

317

P.3.070 - Methodological issues in the outcomes assessment of a new, atypical antipsychotic

M.F. Drummond, M.R.J. Knapp, T.P. Burns, K.D. Miller, R. Ruiz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

318

P.3.071 - The effects of neonatal bilateral ventral hippocampal lesions on behavior in the rat

E.W.P.M. Daenen, G.M.F.C. Dautzenberg, G. Wolterink, J.M. Van Ree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

319

P.3.072 - Enzymes of the antioxidant system in type II schizophrenia

V.R. Paunovic, C.D. Miljevic, A. Nikolic, Z. Saicic, T. Babinski, M.B. Spasic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

320

P.3.066 - The atypical profile of ‘Seroquel’ (ICI 204,636) is supported by the lack of sustained elevation of plasma prolactin in schizophrenic patients

W.W. Hong, L.A. Arvanitis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 305 KB

english, 1996

321

P.3.065 - Two long-term neuroleptic resistant patients treated by ‘Seroquel’ (ICI 204,636) an atypical neuroleptic

M. Avnon, V. Goldin, Y. Neissburg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

322

P.3.052 - First episode schizophrenia: Treatment and outcome

Mario Amore, Magnani Katia, Serena D’Ambrosio, Josè Mesa Mesa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 315 KB

english, 1996

323

P.3.050 - Neuroleptic malignant syndrome and psychosis in two siblings with gangliosidosis type II

I. Manor, H. Hermesh, H. Munitz, A. Weizman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

324

P.3.051 - Muscle enzymes and white blood count as risk factors for the neuroleptic malignant syndrome

H. Hermesh, I. Manor, M. Gianella, H. Munitz, A. Weizman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

325

P.3.048 - Bizarre delusions and age of onset in schizophrenic patients

D.G. Dikeos, G.N. Papadimitriou, E.G. Daskalopoulos, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

326

P.3.049 - Depressive symptoms in stable chronic schizophrenia: Prevalence and relationship to psychopathology and medication status

C. Mulholland, D. Baynes, R. Montgomery, G. Lynch, G. MacFlynn, C. Kelly, S.J. Cooper, D.J. King

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

327

P.3.047 - Risperidone in the treatment of psychosis and concomitant buccolinguo-masticatory dyskinesis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 293 KB

english, 1996

328

P.6.026 - Salivary cortisol response to psychological stress in healthy adults and children: Comparison of two different stimuli

L.M.C. Jansan, P.J. Gademan, R.C.J. de Jonge, C.C. Gispen-de Wied

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

329

P.3.041 - Acute phase efficacy and safety of olanzapine: A review

A. Kuntz, P. Tran, M.A. Dellva, T. Sanger, C. Beasley, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

330

P.3.042 - Long-term continuation therapy with the novel antipsychotic olanzapine: A review of the clinical experience

P.V. Tran, M.A. Dellva, V. Rampey, G.D. Tollefson, C.M. Beasley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

331

P.3.037 - Antibodies to human heat shock protein in patients with schizophrenia and major depression

P. Sirota, D. Mazeh, A. Novogrotsky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

332

P.3.038 - The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia

Pinkhas Sirota, Israel Ben-David, Keren Luca-Haimovici, Joseph Zohar, Ruth Gross-Isseroff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

333

P.3.039 - Regulation of AP-1 transcription complex in the CNS by antipsychotics

P. Rogue, A.N. Malviya, G. Vincendon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

334

P.3.025 - Reduction of hospital days in sertindole treated patients-one year findings

A. Braus, A. Nabulsi, R. Mack, T. Sebree, K. Holgate

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

335

P.3.023 - Positron emission tomography in schizophrenic patients treated with sertindole and haloperidol

M.S. Buchsbaum, E. Hazlett, M. Haznedar, R.J. Mack, T.B. Sebree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

336

S.22.03 - Panic disorder: Do we know the best way to treat it?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 318 KB

english, 1996

337

S.22.01 - Animal models of panic disorder — emphasis on face and predictive validity

F. Jenck, J.R. Martin, J.-L. Moreau

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

338

S.19.03 - The effects of neuroleptics in rats with neonatal hippocampal damage; A search for more effective treatment of schizophrenia

B.K. Lipska, S.M. Lillrank, D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

339

S.19.02 - Developmental processes and immunology in schizophrenia

Norbert Müller, Markus Schwarz, Michael Riedel, Manfred Ackenheil

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

340

S.19.01 - Dopamine-GABA interactions in relation to schizophrenia

Francine M. Benes

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 320 KB

english, 1996

341

S.18.05 - 5-HT6 and 5-HT7 receptors: New targets for neuropsychiatry

A.J. Sleight, F.G. Boess, F.J. Monsma Jr., A. Bourson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 328 KB

english, 1996

342

S.16.02 - Social defeat in rats as model for depression

J.M. Koolhaas, P. Meerlo, S.F. de Boer, J.H. Strubbe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

343

S.15.04 - Inflammation and anti-inflammatory treatment strategies in Alzheimer's disease

B. Winblad, M. Schultzberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

344

S.14.04 - Early intervention and the course of illness

N.R. Schooler, M.S. Keshavan, G.L. Haas, J.A. Sweeney

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 65 KB

english, 1996

345

S.14.03 - Relapse prevention with neuroleptics in schizophrenia: The role of their bioavailability and pharmacodynamic profile

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 222 KB

english, 1996

346

S.14.02 - Course of illness in schizophrenia in relation to duration of initially untreated psychosis

J.L. Waddington, P.J. Scully, G. Coakley, A. Kinsella

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

347

S.13.05 - Treatment options in refractory bipolar disorder, methodological problems and clinical opportunities

Willem A. Nolen, H.C. Rümke groep, Willem Arntsz Huis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

348

S.06.04 - The course of primary and secondary negative symptoms in a placebo-and comparator-controlled trial of the typical antipsychotic olanzapine

G.D. Tollefson, T.M. Sanger, C.M. Beasley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 167 KB

english, 1996

349

S.06.03 - Negative symptoms and risperidone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 317 KB

english, 1996

350

S.06.02 - Negative symptoms and sertindole

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

351

S.06.01 - The treatment of the schizophrenic patient: How far have we come in meeting the challenge

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 323 KB

english, 1996

352

S.05.01 - MAO and COMT: basic functions and therapeutic indications

J.G. Richards, J. Saura, Z. Bleuel, P. Malherbe, A.M. Cesura, E. Borroni, J. Gottowik, J. Gray

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

353

P.3.024 - The efficacy and safety of three doses of sertindole versus three doses of haloperidol in schizophrenic patients

R.W. Baker, R.J. Mack, D.D. Morris, T.B. Sebree, K.B. Kashkin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

354

P.3.019 - An aminopyrimidine with potent affinity for both dopamine and serotonin reoeptors

D. Wustrow, H. Akunne, T. Belliotti, M.D. Davis, T. Heffner, S. Kesten, L. Meltzer, T. Pugsley, L. Wise

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

355

P.3.017 - Extrapyramidal symptoma and tolerability of olanzapine versus haloperidol in acute treatment

M.A. Dellva, W. Satterlee, P.V. Tran, C. Beasley, M. Greaney, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

356

P.1.048 - The effect of antidepressants on platelet serotonin level and serotonin uptake in rats genetically selected for these traits

L. Čičin-Šain, A. Fröbe, B. Jernej

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 314 KB

english, 1996

357

P.1.049 - Messenger RNA for platelet 5HT transporter protein: Studies in rats with constitutionally altered serotonin homeostasis

B. Jernej, D. Hranilović, L. Čičin-Šain

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 168 KB

english, 1996

358

P.1.050 - Pharmacoethological investigation GABA-ergic regulation of aggression and depression: Animal models

I.V. Belozertseva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 315 KB

english, 1996

359

P.1.051 - Tryptophan depletion and neurohormonal regulation in remitted patients with seasonal affective disorder

B. Hesselmann, A. Neumeister, N. Praschak-Rieder, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

360

P.1.052 - Left hemispheric relative hypoperfusion in depressed patients with seasonal affective disorder responding to light therapy

N. Praschak-Rieder, A. Neumeister, B. Hesselmann, U. Bailer, N. Asenbaum, I. Podreka, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

361

P.6.037 - Utilization of laser therapy in the complex treatment of Tourette's syndrome in children

G.M. Janumova, L.B. Ivanov, V.P. Zykov, N.V. Alekseeva, L.N. Dakhayeva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 61 KB

english, 1996

362

P.1.053 - Combined pharmakotherapy (Tramadon and mianserin) in chronic pain syndrome

Munjiza G. Marko

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

363

P.1.054 - Time-blind assessment of antidepressant efficacy in depressed patients

E. Corruble, D. Purper, C. Payan, A.J. Puech, J.D. Guelfi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

364

P.1.055 - Reduced 5-HT in CSF: Trait or state marker for suicidality?

U. Becker, G. Laakmann, T. Baghai, K. Kuhn, B. Pfeifer, G. Kauert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 307 KB

english, 1996

365

P.1.056 - Blunted reaction to the citalopram challenge test in patients with major depression

T. Kapitany, S.D. Schindler, B. Hesselmann, M. Schindl, C. Barnas, W. Sieghart, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

366

P.1.057 - Neuroendocrine challenge of serotonergic function with citalopram in healthy volunteers

T. Kapitany, B. Hesselmann, S.D. Schindler, M. Schindl, C. Barnas, W. Sieghart, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

367

P.1.058 - Comparative efficacy of moclobemide and imipramine on anxiety features in major depression- a meta-analysis of double blind comparative studies against placebo

Alexandra Delini-Stula, Anne Cameron, Jules Angst

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 312 KB

english, 1996

368

P.1.076 - The NMDA receptor and the olfactory bulbectomised rat model of depression

A.M. Redmond, J.P. Kelly, B.E. Leonard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

369

P.1.077 - The antidepressant effect and tolerability of moclobemide — elderly versus younger patients

Ž. Stanković, Dj. Živković, D. Bugarski, A. Damjanović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

370

P.1.078 - Pindolol augments the antidepressant efficacy of fluoxetine. Results of a double-blind, controlled trial

V. Pérez, I. Gilaberte, D. Faries, E. Alvarez, F. Artigas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 308 KB

english, 1996

371

P.1.079 - Clinical and experimental sleep study of acute and long-term effects of mood stabilizes

S.N. Mosolov, L.N. Nerobkova, T.A. Voronina, J.P. Macher

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

372

P.1.082 - Clinico-pharmacokinetic prognosis of prophylactic efficacy of carbamazepine, oxcarbazepine and sodium valproate in affective and schizoaffective disorders

M. Kouzavkova, S. Mosolov, E. Kostiukova, A. Singin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

373

P.1.083 - Use of dopaminergic agonist in treatment of chronic depressive patients resistant to tricyclic antidepressants

E. Tsucarzi, S. Mosolov, E. Missionznik, A. Sharov, M. Uzbekov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 311 KB

english, 1996

374

P.1.084 - Quantitative video-analysis of gait in depressed inpatients

T. Hergueta, F. Delgado, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

375

P.1.085 - Vitamin E inhibits cellular accumulation of desipramine and prevents antidepressant induced β-adrenoceptor down-regulation in vitro and in vivo

U. Kientsch, U.E. Honegger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 162 KB

english, 1996

376

P.2.001 - Abnormalities of hypothalamus-pituitary-adrenal axis function and natural killer cell activity in Alzheimer's disease

G. Griot, P. Prolo, R.G. Masera, A. Lazzero, M. Mantovan, A. Staurenghi, M.L. Sartori, L. Tarenzi, L. Ravizza, A. Angeli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 2.74 MB

english, 1996

377

P.2.002 - Corticotropin-releasing hormone (CRH) neurons in the hypothalamic paraventricular nucleus of depressed and non-depressed parkinsonian patients with and without dementia

W.J.G. Hoogendijk, J.S. Purba, M.A. Hofman, R.A.I. de Vos, E.N.H. Jansen Steur, D.F. Swaab

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

378

P.2.003 - Peduncular hallucinosis: SSRI efficacy brings new arguments for an old theory

C. Gilles, P. Wuilmart, L. Lasseaux, J.M. Tecco, P. Lorimier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 305 KB

english, 1996

379

P.2.004 - Free radical formation level in rabbit brain after experimental cranlocerebral trauma

M.L. Demchuk, M.Sh. Promyslov, L.V. Poryadina

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

380

P.2.005 - Nimotop influence on free radical processes in the CSF of patients with subarachnoid haemorrhages

I.A. Arefyeva, M.L. Demchuk, A.A. Dausheva, O.B. Belousova, A.E. Myakota

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

381

P.2.006 - Changes in composition of phospholipids and fatty acids in rat brain during aging

D. Řípovà, V. Němcovà

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 303 KB

english, 1996

382

P.2.007 - Calcium channel blockers prevent memory impairment induced by the beta-blockers acebutolol and metoprolol

M. Lazarova-Bakarova, M. Genkova-Papasova, B. Petkova, E. Bojanova, D. Staneva-Stoycheva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 164 KB

english, 1996

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски